Mural Oncology plc currently has no Cashu-related articles
Key Stats
Market Cap
44.87M
Dividend Yield
0.00%
P/E Ratio
-0.35
EPS
-7.58
Revenue
-
Avg. Volume
487.57K
About
What does MURA do?
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
